Item request has been placed!
×
Item request cannot be made.
×
Processing Request
The Bcl-2 gene is differentially regulated by IL-2 and IL-4: role of the transcription factor NF-AT.
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- Additional Information
- Source:
Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8711562 Publication Model: Print Cited Medium: Print ISSN: 0950-9232 (Print) Linking ISSN: 09509232 NLM ISO Abbreviation: Oncogene Subsets: MEDLINE
- Publication Information:
Publication: <2002->: Basingstoke : Nature Publishing Group
Original Publication: Basingstoke, Hampshire, UK : Scientific & Medical Division, MacMillan Press, c1987-
- Subject Terms:
- Abstract:
The murine TS1alphabeta T cell line expresses the anti-apoptotic protein Bcl-2 upon IL-2 stimulation, whereas IL-4-mediated growth of this cell line proceeds in the absence of Bcl-2 expression. In addition, IL-4 stimulation inhibits Bcl-2 expression and modulates its mRNA level. IL-2-induced DNA binding activity for these transcription factors is sensitive to phosphatidylinositol 3 kinase inhibitor wortmannin and to Rho inhibitor Clostridium difficile toxin B, which inhibit IL-2-induced Bcl-2 expression. NF-AT transcription factor appears to be the most important in the control Bcl-2 expression, since inhibition of the calcium-calmodulin-dependent phosphatase calcineurin, which regulates NF-AT activity, downregulates Bcl-2 expression in IL-2-stimulated cells. Constitutive expression of this phosphatase also upregulates Bcl-2 expression in IL-4-stimulated cells. In addition, a dominant negative NF-AT expression vector downregulates Bcl-2 expression in IL-2-stimulated cells. These results suggest that IL-2 induction of Bcl-2 expression may be directly or indirectly mediated by NF-AT.
- Accession Number:
0 (Androstadienes)
0 (Bacterial Proteins)
0 (Bacterial Toxins)
0 (Calcineurin Inhibitors)
0 (DNA-Binding Proteins)
0 (Interleukin-2)
0 (NFATC Transcription Factors)
0 (Nuclear Proteins)
0 (Proto-Oncogene Proteins c-bcl-2)
0 (Sp1 Transcription Factor)
0 (Transcription Factor AP-1)
0 (Transcription Factors)
0 (toxB protein, Clostridium difficile)
207137-56-2 (Interleukin-4)
83HN0GTJ6D (Cyclosporine)
EC 3.1.3.16 (Calcineurin)
WM0HAQ4WNM (Tacrolimus)
XVA4O219QW (Wortmannin)
- Publication Date:
Date Created: 19981015 Date Completed: 19981028 Latest Revision: 20181201
- Publication Date:
20221213
- Accession Number:
10.1038/sj.onc.1202049
- Accession Number:
9771966
No Comments.